Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-28 4:30 pm Purchase | 2025-01-24 | 13D | Neuphoria Therapeutics Inc. NEUP | Apeiron Investment Group Ltd. | 72,618 4.500% | 72,618 (New Position) | Filing History |
| 2024-10-07 6:10 pm Purchase | 2024-10-03 | 13D | Bionomics Limited BNOX | Apeiron Investment Group Ltd. | 23,040,875 8.900% | 23,040,875 (New Position) | Filing History |
| 2024-09-30 09:31 am Purchase | 2024-09-24 | 13G | Rezolve AI Limited Ordinary Shares RZLV | Apeiron Investment Group Ltd. | 18,281,638 10.400% | 18,281,638 (New Position) | Filing History |
| 2024-02-13 4:29 pm Purchase | 2023-12-31 | 13G | Atai Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 33,885,999 20.100% | 1,214,297 (+3.72%) | Filing History |
| 2023-06-02 5:00 pm Sale | 2023-06-01 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 0 0.000% | -3,441,661 (Position Closed) | Filing History |
| 2023-05-23 4:50 pm Unchanged | 2023-05-23 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,441,661 11.100% | 0 (Unchanged) | Filing History |
| 2023-03-09 5:15 pm Purchase | 2023-03-09 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,441,661 11.200% | 2,200 (+0.06%) | Filing History |
| 2023-02-10 08:39 am Purchase | 2022-12-31 | 13G | Atai Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 32,671,702 19.400% | 612,198 (+1.91%) | Filing History |
| 2022-11-21 06:15 am Unchanged | 2022-11-21 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 0 (Unchanged) | Filing History |
| 2022-11-02 11:58 am Unchanged | 2022-11-02 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 0 (Unchanged) | Filing History |
| 2022-07-19 5:30 pm Purchase | 2022-07-14 | 13D | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 210,000 (+6.50%) | Filing History |
| 2022-02-10 5:15 pm Purchase | 2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 3,229,461 10.600% | 577,618 (+21.78%) | Filing History |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Atai Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 32,059,504 19.700% | 32,059,504 (New Position) | Filing History |
| 2021-12-30 4:31 pm Purchase | 2021-12-20 | 13D | Neuphoria Therapeutics Inc. NEUP | Apeiron Investment Group Ltd. | 33,545,866 27.700% | 33,545,866 (New Position) | Filing History |
| 2021-02-18 4:15 pm Purchase | 2021-02-08 | 13G | Sensei Biotherapeutics, Inc. SNSE | Apeiron Investment Group Ltd. | 2,651,843 8.700% | 2,651,843 (New Position) | Filing History |